Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG (BAYN)

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

Bayer : Sources Sought - Preventive Maintenance & service solution on existing Bayer/Medrad and Acist Medical Systems Radiology Injectors software PM Contrast Dye Injectors

share with twitter share with LinkedIn share with facebook
share via e-mail
0
12/02/2016 | 02:04pm CET

Sources Sought - Preventive Maintenance & service solution on existing Bayer/Medrad and Acist Medical Systems Radiology Injectors software PM Contrast Dye Injectors

Document Type: Sources Sought

Posted Date: 01-DEC-16

Location: Department of Veterans Affairs, Hampton VAMC, Department of Veterans Affairs Medical Center

Classification Code: J - Maintenance, repair & rebuilding of equipment

Subject: Preventive Maintenance & service solution on existing Bayer/Medrad and Acist Medical Systems Radiology Injectors software PM Contrast Dye Injectors

Solicitation Number: VA24617Q0035

Internet Link: https://www.fbo.gov/index?s=opportunity&mode=form&id=e7ead631a6ec3bea7a47a074500be75c&tab=documents&tabmode=list

(c) 2013 Federal Information & News Dispatch, Inc., source Federal Documents

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAYER AG
12/02 BAYER : Sources Sought - Preventive Maintenance & service solution on existing B..
12/02 BAYER : Sources Sought Notice - J-- Preventive Maintenance & service solution on..
11/24 BAYER : supports public access to safety-relevant crop protection study reports
11/23 Global Milnacipran HCl Market 2016- Pfizer Inc (US), Bayer HealthCare Pharmac..
11/22 BAYER : Announces Phase III Study to Evaluate New Pediatric Formulation of Nifur..
11/21 Global Polyurethane Market - DOW Chemical Company, Bayer AG, Sekisui Chemical..
11/21 COVESTRO : Assigned Patent
11/18 Global Polyols Market - BASF SE, Mitsui Chemicals, Inc., Bayer AG, Chemtura C..
11/18 BAYER : Gov. Nixon Meets With Bayer AG CEO Werner Baumann to Discuss Proposed Ba..
11/17 Global Macitentan Market 2016- Pfizer, Inc. (US), Bayer HealthCare Pharmaceut..
More news
Sector news : Pharmaceuticals - NEC
12/03DJJOHNSON & JOHNSON : Boosts Actelion Bid -Bloomberg
12/02 Pharma execs weigh in on possible changes under Trump
12/02DJJOHNSON & JOHNSON : Jury Orders Johnson & Johnson to Pay More Than $1 Billion in..
12/01DJValeant Deal Talks Collapse Over Price -- WSJ
12/01DJCSL : Eyes Biggest Undertaking Yet in Heart Therapy Trial
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
11/30 A Guide To Investing In Water
11/29 Blueprint's candidate for advanced liver cancer shows anti-tumor activity in ..
11/29 A YEAR IN REVIEW : Integer Investments
11/28 Einhorn a fan of Bayer with or without Monsanto
11/28 5 Dividends That Make The Difference
Advertisement
Financials (€)
Sales 2016 46 747 M
EBIT 2016 8 627 M
Net income 2016 4 732 M
Debt 2016 16 430 M
Yield 2016 3,08%
P/E ratio 2016 15,26
P/E ratio 2017 13,56
EV / Sales 2016 1,89x
EV / Sales 2017 1,75x
Capitalization 72 069 M
More Financials
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 107 €
Spread / Average Target 22%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Johannes M. Dietsch Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Human Resources, Technology & Sustainability
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BAYER AG-25.06%76 831
JOHNSON & JOHNSON9.00%304 591
PFIZER INC.-2.01%191 942
ROCHE HOLDING LTD.-19.61%188 878
NOVARTIS AG-19.07%178 737
MERCK & CO., INC.15.85%168 544
More Results